At a glance
- Originator University of California, San Diego
- Class Antineoplastics; Cyclic peptides; Pancreatic hormones; Pituitary hormone release inhibiting hormones
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 08 Apr 2003 No development reported - Preclinical for Cancer in USA (unspecified route)
- 20 Jul 2001 This compound is still in active development
- 14 Jul 1997 Preclinical development for Cancer in USA (Unknown route)